wet AMD

water tap outside
Biotech

4DMT restructures pipeline, extending cash runway through 2028

4DMT is axing two clinical programs and shutting off funds for three other assets, with resources to be pivoted toward gene therapy 4D-150.
Gabrielle Masson Jan 10, 2025 2:00pm
eye doctor opthalmology phoropter glasses eye disease vision

Outlook's eye disease drug fails to match Lucentis, sinking stock

Nov 27, 2024 8:40am
eye eyeball eye art

Adverum's gene therapy reduces treatment burden in wet AMD

Feb 8, 2024 11:17am
very busy graphic of scientists working on an eye with one standing on a ladder preparing drops another set to apply a cont

4DMT links gene therapy to drop in Eylea injections

Feb 5, 2024 6:23am
very busy graphic of scientists working on an eye with one standing on a ladder preparing drops another set to apply a cont

Eyconis launches with $150M and Ascendis' eye disease meds

Jan 29, 2024 11:03am
eye see vision pupil eyelash

Regenxbio-AbbVie in-office gene therapy clears phase 2 test

Jan 17, 2024 9:42am